MLTX Investors Have Opportunity to Join MoonLake Immunotherapeutics Fraud Investigation with the Schall Law Firm
A new investigation by The Schall Law Firm examines possible securities law violations by MoonLake Immunotherapeutics. Investors in the NASDAQ-listed company may have an opportunity to participate in a fraud claim if they believe they have been impacted by these allegations.